Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India
Tulika Seth(Manipal Academy of Higher Education), Usha Rani Thota(Osmania Medical College), Kapil Garg(SMS Medical College), Anupam Datta(ATUM (United States)), Shailendra Verma(University of Lucknow), Suresh Hanagavadi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Prakas Kumar Mandal(Medical College and Hospital, Kolkata)
Cited by 15
Related Papers
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Platelet activation determines the severity of thrombocytopenia in dengue infection
|Scientific Reports|2017|198
Autologous stem cell transplantation in refractory Asherman′s syndrome: A novel cell based therapy
|Journal of Human Reproductive Sciences|2014|184
Environmental and occupational determinants of lung cancer
|Translational Lung Cancer Research|2019|171
Recommendations for screening and early detection of common cancers in India
|The Lancet Oncology|2015|125